Literature DB >> 9154157

Tumor collagenase stimulatory factor (TCSF) expression and localization in human lung and breast cancers.

M Polette1, C Gilles, V Marchand, M Lorenzato, B Toole, J M Tournier, S Zucker, P Birembaut.   

Abstract

Tumor cell-derived collagenase stimulatory factor (TCSF) stimulates in vitro the biosynthesis of various matrix metalloproteinases involved in tumor invasion, such as interstitial collagenase, gelatinase A, and stromelysin 1. The expression of TCSF mRNAs was studied in vivo, using in situ hybridization and Northern blotting analysis, in seven normal tissues and in 22 squamous cell carcinomas of the lung, and in seven benign proliferations and in 22 ductal carcinomas of the mammary gland. By in situ hybridization, TCSF mRNAs were detected in 40 of 44 carcinomas, in pre-invasive and invasive cancer cells of both lung and breast cancers. TCSF mRNAs and gelatinase A mRNAs were both visualized in the same areas in serial sections in breast cancers, and were expressed by different cells, tumor cells, and fibroblasts. The histological results were confirmed by Northern blot analysis, which showed a higher expression of TCSF mRNAs in cancers than in benign and normal tissues. These observations support the hypothesis that TCSF is an important factor in lung and breast tumor progression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9154157     DOI: 10.1177/002215549704500508

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  26 in total

1.  Clinical impact of HAb18G/CD147 expression in esophageal squamous cell carcinoma.

Authors:  Shaojun Zhu; Yanhong Li; Li Mi; Yang Zhang; Li Zhang; Li Gong; Xiujuan Han; Li Yao; Miao Lan; Zhinan Chen; Wei Zhang
Journal:  Dig Dis Sci       Date:  2011-07-26       Impact factor: 3.199

2.  N-acetylglucosaminyltransferase IVa regulates metastatic potential of mouse hepatocarcinoma cells through glycosylation of CD147.

Authors:  Jianhui Fan; Shujing Wang; Shengjin Yu; Jingna He; Weilong Zheng; Jianing Zhang
Journal:  Glycoconj J       Date:  2012-06-27       Impact factor: 2.916

3.  Immunolocalization of matrix metalloproteinases and their inhibitors in clinical specimens of bone metastasis from breast carcinoma.

Authors:  S Lhoták; L J Elavathil; S Vukmirović-Popović; W C Duivenvoorden; R G Tozer; G Singh
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

4.  CD147, CD44, and the epidermal growth factor receptor (EGFR) signaling pathway cooperate to regulate breast epithelial cell invasiveness.

Authors:  G Daniel Grass; Lauren B Tolliver; Momka Bratoeva; Bryan P Toole
Journal:  J Biol Chem       Date:  2013-07-25       Impact factor: 5.157

5.  Tumorigenic potential of extracellular matrix metalloproteinase inducer.

Authors:  S Zucker; M Hymowitz; E E Rollo; R Mann; C E Conner; J Cao; H D Foda; D C Tompkins; B P Toole
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

6.  Links between CD147 function, glycosylation, and caveolin-1.

Authors:  Wei Tang; Sharon B Chang; Martin E Hemler
Journal:  Mol Biol Cell       Date:  2004-06-16       Impact factor: 4.138

7.  [EMMPRIN (CD147). A new key protein during tumor progression in bladder cancer].

Authors:  R Nawroth; R Stöhr; A Hartmann; J E Gschwend; M Retz
Journal:  Urologe A       Date:  2008-09       Impact factor: 0.639

8.  EMMPRIN-mediated MMP regulation in tumor and endothelial cells.

Authors:  Stéphanie Caudroy; Myriam Polette; Béatrice Nawrocki-Raby; Jian Cao; Bryan P Toole; Stanley Zucker; Philippe Birembaut
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

9.  Stereomicroscopic fluorescence imaging of head and neck cancer xenografts targeting CD147.

Authors:  J Robert Newman; John P Gleysteen; Christopher F Barañano; Jennifer R Bremser; Wenyue Zhang; Kurt R Zinn; Eben L Rosenthal
Journal:  Cancer Biol Ther       Date:  2008-04-14       Impact factor: 4.742

Review 10.  CD147 immunoglobulin superfamily receptor function and role in pathology.

Authors:  Kathryn T Iacono; Amy L Brown; Mark I Greene; Sandra J Saouaf
Journal:  Exp Mol Pathol       Date:  2007-09-07       Impact factor: 3.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.